WallStreetZenWallStreetZen

NASDAQ: MYGN
Myriad Genetics Inc Stock Ownership - Who owns Myriad Genetics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Myriad Genetics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul BisaroDirector2026-05-147,500$3.69
$27.64kBuy
Brian J. DonnellyChief Commerical Officer2026-05-0155,975$4.80
$268.68kSell
Dale MuzzeyChief Scientific Officer2026-04-14946$4.91
$4.64kSell
Mark VerrattiChief Operating Officer2026-04-141,069$4.91
$5.25kSell
Benjamin Richard WheelerChief Financial Officer2026-03-22549$4.58
$2.51kSell
Mark VerrattiChief Operating Officer2026-03-222,055$4.58
$9.41kSell
Dale MuzzeyChief Scientific Officer2026-03-222,019$4.58
$9.25kSell
Mark VerrattiChief Operating Officer2026-03-159,096$4.66
$42.39kSell
Kevin Richard HaasChief Technology Officer2026-03-153,355$4.66
$15.63kSell
Kevin Richard HaasChief Technology Officer2026-03-158,382$4.66
$39.06kSell

1 of 5

MYGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MYGN insiders and whales buy or sell their stock.

MYGN Shareholders

What type of owners hold Myriad Genetics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC132.35%125,000,000$488.75MInstitution
Blackrock Inc9.41%8,889,644$34.76MInstitution
Millennium Management LLC7.06%6,668,817$26.08MInstitution
Glenview Capital Management LLC5.73%5,411,978$21.16MInstitution
D E Shaw Co Inc4.76%4,499,724$17.59MInstitution
State Street Corp4.68%4,424,027$17.30MInstitution
Vanguard Capital Management LLC4.16%3,924,525$15.34MInstitution
Morgan Stanley3.36%3,168,742$12.39MInstitution
Vanguard Portfolio Management LLC2.73%2,582,231$10.10MInstitution
Goldman Sachs Group Inc 12.51%2,366,092$9.25MInstitution

1 of 3

MYGN vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MYGN95.31%4.69%Net SellingNet Selling
LAB48.62%51.38%Net BuyingNet Selling
PRE11.80%8.26%
FLGT57.02%42.98%Net SellingNet Selling
IMDX18.53%81.47%Net BuyingNet Buying
View Top Diagnostic & Research Stocks

Myriad Genetics Stock Ownership FAQ

Who owns Myriad Genetics?

Myriad Genetics (NASDAQ: MYGN) is owned by 225.39% institutional shareholders, 11.08% Myriad Genetics insiders, and 0.00% retail investors. Orbimed Advisors LLC is the largest individual Myriad Genetics shareholder, owning 125.00M shares representing 132.35% of the company. Orbimed Advisors LLC's Myriad Genetics shares are currently valued at $488.75M.

If you're new to stock investing, here's how to buy Myriad Genetics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.